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A B S T R A C T
Purpose: Imaging studies in juvenile myoclonic epilepsy (JME) have shown abnormalities of the
thalamus and frontal cortex. The purpose of this study was to systematically investigate the
morphological changes in the deep gray matter (GM) structures using techniques of voxel based
morphometry (VBM), MR volumetry and shape analysis.
Methodology: The study included 40 patients with JME (M:F = 21:19; age 22.8  5.3 years) and 19
matched controls (M:F = 13:6; age 24.5  4.2 years). All subjects underwent MRI using standard protocol
that included T1-3D TFE (Turbo Field Echo) images with 1 mm thickness. VBM analysis and MR volumetry
were performed. The volumes of deep subcortical GM structures were extracted and vertex-wise shape
analysis was performed using FSL-FIRST (FSL-Integrated Registration and Segmentation Toolbox) software.
Results: VBM analysis with a thalamic mask revealed focal thalamic alterations in the anteromedial
aspect of the thalamus (p < 0.05, false discovery rate (FDR) corrected) which remained signiﬁcant after
adjusting for age, gender and intracranial volume (ICV). Signiﬁcant volume loss was noted in both the
thalami. Vertex-wise shape analysis showed signiﬁcant focal surface reductions in the thalami
bilaterally in patients that were predominantly seen in the medial as well as lateral aspects of the
thalamus (p < 0.05, FDR corrected). The disease duration correlated with left hippocampus volume while
age of onset correlated with right hippocampus volume.
Conclusions: This study conﬁrms the presence of thalamic alterations in patients with JME. Shape
analysis technique provided complementary information and disclosed the presence of focal atrophic
changes in patients’ thalami. The striatum and hippocampus did not show any signiﬁcant alterations.
 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Juvenile myoclonic epilepsy (JME) is the most common and
well-deﬁned idiopathic generalized epilepsy (IGE), established as
an epileptic syndrome in 1989. The disorder may be inherited and
has equal gender distribution. Patients manifest with myoclonic
jerks starting often at puberty, sometimes associated with
generalized tonic–clonic seizures (GTCS) and infrequently
absences. Myoclonic jerks are bilateral, single or repetitive,
arrhythmic, predominantly in the arms, not associated with
disturbance in consciousness, occurring shortly after awakening
and often precipitated by sleep deprivation.1–3 Patients respond to
sodium valproate but some anti-epileptic drugs (AEDs) like
carbamazepine and phenytoin might worsen the myoclonic jerks* Corresponding author at: NIMHANS, Bangalore 560 029, Karnataka, India.
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http://dx.doi.org/10.1016/j.seizure.2013.01.001and absence seizures. Standard Electroencephalography (EEG) in
JME typically shows 3–6 Hz generalized spike wave or polyspike-
wave activity, with fronto-central predominance. EEG plays an
important role in the diagnosis.3–5 In a study by Holmes et al., all 10
patients had epileptiform discharges, which localized to sources
that included orbitofrontal/medial frontopolar cortex, while basal-
medial temporal lobe sources were observed in 50% of patients.6
Recent neuroimaging studies have contributed immensely to the
understanding of JME by revealing focal brain abnormalities.
Routine magnetic resonance imaging (MRI) in patients with
JME is often normal on visual inspection. Multiple MRI studies
using advanced image processing methods and newer MR
contrasts have revealed abnormalities of the thalamus, frontal
cortex and thalamo-frontal connections in these patients.7–14
Among the subcortical structures, thalamus is most studied area
and has been investigated in detail using multiple analysis and
imaging techniques like voxel based morphometry (VBM),
volumetry, shape analysis and MR spectroscopy (MRS).11,13,15–19vier Ltd. All rights reserved.
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basal ganglia structures and hippocampus in JME.13,15,20–22 The
results of these studies support the presence of structural and
biochemical changes in basal ganglia. Hippocampus does not
appear to be directly involved in generalized seizure disorder. In
contrast, hippocampus involvement in JME has been supported by
the presence of metabolic abnormalities on MRS and CBF changes
on SPECT studies.13,23
Most of the previous imaging studies that have used whole
brain voxel wise approach to analyze structural MRI have failed to
identify abnormalities in basal ganglia and hippocampus.
In view of lack of consistency of previous results, in the present
study we investigated the morphological changes in the deep gray
matter structures and hippocampus by using multiple analysis
methods (which includes VBM, volumetry and shape analysis to
the structural MRI data).
2. Materials and methods
2.1. Subjects
Forty JME patients (M:F = 21:19; age at evaluation = 22.8  5.3
years) and 19 age-matched controls (M:F = 13:6; age at
evaluation: = 24.5  4.2 years) were enrolled for the study. All
patients were examined by a specialist in epilepsy (SS) and the
diagnosis of JME was based on the ILAE criteria for JME.24,25 Patients
were primarily recruited for another study on ‘sleep in JME’ and were
also simultaneously evaluated for the present study. Patients with
other medical illnesses or on any medications (other than sodium
valproate) known to affect sleep, and those with substance abuse
were excluded. Nineteen normal healthy age-matched volunteers
without family history of seizures or any other neurodegenerative
disease were enrolled as controls. All patients underwent a structured
evaluation that included recording of detailed clinical, family and
treatment history, neurological examination, 16-channel digital EEG
using the international 10–20 system of electrode placement, MRI
and other investigations (when indicated).
All the controls were clinically examined by a neurologist.
Subjects with any other neurological or signiﬁcant psychiatric
illnesses and those who were claustrophobic or had contra-
indications for MRI were excluded. The present study was
approved by the Institute’s Ethics Committee. A written informed
consent was obtained from all subjects (patients and healthy
volunteers) before the initiation of study.
2.2. MRI
MR imaging of all the subjects was performed on an Achieva 3T
MR imaging scanner (Achieva, Philips Healthcare, Best, Nether-
land) with an 8-channel head coil. The study included conventional
MR imaging techniques including standard T2-weighted and T1-
weighted, as well as Fluid Attenuation and Inversion Recovery
(FLAIR), T2 gradient echo (GRE) and Diffusion weighted imaging
(DWI) as per standard protocol to exclude presence of other
structural lesions. MR imaging for structural analysis was
performed with following parameters, slice thickness 1.0 mm,
no gap, 160 sections, scanning time 7 min 41 s, TR/TE 10/4.3 ms,
number of signal-intensity averages 1, matrix 256  256, ﬂip angle
8. The ﬁnal voxel size was 1 mm (x)  1 mm (y)  1 mm (z).
2.3. Image processing
2.3.1. Voxel based morphometry
The image processing was performed on Statistical Parametric
Mapping 5 software (SPM5) using VBM tools 5.1 toolbox (Well-
come Department of Imaging Neuroscience, London; http://www.ﬁl.ion.ucl.ac.uk/spm).26 VBM5 uses a uniﬁed segmentation
approach that integrates image registration, MRI inhomogeneity
bias correction, and tissue classiﬁcation. The VBM tools 5.1
segmentation algorithm in SPM5 additionally warps the prior
images to the data and tries to minimize the impact of the template
and the prior images.27 It also applies Hidden Markov Field model
to the segmented images and removes the uncorrected voxels that
were unlikely to represent determined tissue. The image pre-
processing as integrated in VBM tools 5.1 involves a number of
deﬁned stages:
Normalization of gray/white matter images. The original T1
images were spatially normalized to MNI template image given in
the SPM5 package, to generate optimally normalized whole brain
template. Thus the images are in a uniform space so that a speciﬁc
location in one subject’s brain scan corresponds to the same
location in another subject.
Segmentation and extraction of normalized whole brain images.
The optimally normalized whole brain structural images, were
then segmented into gray and white matter images.
Modulation. As a result of nonlinear spatial normalization, the
volumes of certain brain regions may grow, whereas others may
shrink. In order to preserve the volume of a particular tissue (gray
or white matter or CSF) within a voxel, modulation and
smoothening were required. This involved multiplying (or
modulating) voxel values in the segmented images by the Jacobian
determinants derived from the spatial normalization step.
Smoothing. The modulated gray matter images were then
smoothed with a Gaussian ﬁlter to make the data less noisy. The
previous modulation step itself involves some smoothening in its
process.27 We used Gaussian ﬁlter of 8 mm Full width half
maximum (FWHM) for smoothening. The process of smoothing
conditioned the residuals to conform more closely to the Gaussian
random ﬁeld model underlying the statistical process used for
adjusting ‘p’ values.28
This normalized, segmented, modulated, and smoothed gray
matter images with a voxel size of 1 mm3 were used for further
statistical analysis. On VBM statistical analysis, initially compari-
son was performed between the whole brain GM followed by the
region of interest (ROI) based the comparison using the standard
thalamic mask from Oxford thalamic connectivity atlas.30 The
group comparisons between patients and controls were performed
using Analysis of Covariance (ANCOVA), within the framework of
general linear model in SPM5. Multiple regression model in SPM5
was used to evaluate the GM areas correlating with disease
duration and age of onset as the main regressor. For all these SPM
tests we used age, sex, and ICV as nuisance regressor in the design
matrix (confounding covariates) and a priori decided signiﬁcance
level of false discovery rate (FDR) corrected P < 0.05. The
coordinates of the signiﬁcant voxels were converted into talairach
space.
2.3.2. FSL-FIRST
FSL-integrated registration and segmentation toolbox (FSL-
FIRST) software, version (1.2) (http://www.fmrib.ox.ac.uk/fsl/ﬁrst/
index.html) was used for both evaluation of deep sub cortical
structures.29 FSL-FIRST is a model based automated registration/
segmentation tool. The subcortical structures, viz. bilateral
hippocampus, amygdala, caudate, putamen and thalamus were
segmented from the T1-weighted MR images using FSL-FIRST. The
deformable surfaces of deep GM structures were used to
automatically parameterize the volumetric labels in terms of
meshes. The normalized intensities along the surface of meshes
were sampled and modeled. The shape and appearance model was
based on multivariate Gaussian assumptions. Shape was then
expressed as a mean with modes of variation (principal
components).29 After the automated segmentation by the software
Table 1
The demographic and clinical characteristics of patients with JME.
Features JME (n = 40)
M:F 21:19
Age at evaluation (years) 22.8  5.3
Age at onset (years) 15.4  5.01
Onset of illness <15 years 16
Duration of illness (years) 7.2  5.17
Age at ﬁrst evaluation (years) 16.5  5.5
Age at diagnosis (years) 20.5  4.5
Delay in diagnosis (years) 5.05  4.08
Delay in diagnosis >5 years 24
GTC seizure 37
Myoclonus 40
Absence seizure 3
Worsening on awakening 37
EEG showing spike/polyspike 27
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proper segmentation of all the subcortical structures. Following
the vertex-wise shape analysis along with the surface of the
segmented subcortical structures was performed using age, sex
and total brain volume as covariate of no interest in the statistical
design at p < 0.05 FDR corrected.29 The volumes of thalamus,
hippocampus, amygdala, caudate and putamen were extracted and
statistical comparison was performed using SPSS 15 software.
2.3.3. Statistics
For all the non-SPM/FSL analysis, the data was tested for normal
distribution before implementing parametric tests. Comparison
between groups was done by independent sample t test and
analysis after adjusting for covariates (age, sex and ICV) was
carried out by general linear model (GLM) with categorical
variables as ﬁxed effect and continuous variables as covariates.
Analysis of relationship between volumes of the structures with
disease duration and age of onset of seizures was done using partial
correlations after adjusting age and ICV correlation coefﬁcient (r).
For all the non-SPM/FSL analysis a priori decided signiﬁcance level
of p < 0.05 was considered statistically signiﬁcant with Bonferroni
correction applied for multiple testing.
3. Results
3.1. Clinical characteristics
The demographic and clinical characteristics of the patients are
given in Table 1.
3.2. MRI characteristics
3.2.1. Voxel based morphometry
The VBM analysis comparing the subjects and controls did not
reveal any areas with signiﬁcant GM difference (p < 0.05, FDR
corrected). The VBM analysis with thalamic mask, revealed that
the patients with JME had signiﬁcant GM differences in the medial
aspect of the bilateral thalami (Fig. 1).
3.2.2. Volumetry
Comparison of volumes of thalamus, hippocampus, caudate
nucleus, putamen, amygdala, total WM and total GM between the
patients and healthy controls is summarized in Table 2. TheFig. 1. Statistical parametric map (SPM) result of comparison between the patients wit
statistical signiﬁcance level of p < 0.05 (FDR corrected) and adjusted for age, gender and I
shows the areas of signiﬁcant result on the T1W MRI image. Signiﬁcant alterations noted
discovery rate.thalamic volumes were signiﬁcantly decreased in the patients
relative to the healthy controls (p < 0.05). Rest of the subcortical
structure volumes did not show any signiﬁcant volume differ-
ences.
3.2.3. Volume correlation with clinical parameters
The disease duration showed signiﬁcant correlation with the
total GM volume (r = .354, p = 0.032), left hippocampus
(r = 0.339, p = 0.040), right amygdala (r = .384, p = 0.035), right
caudate nucleus (r = .384, p = 0.019) and right hippocampus
volumes (r = .353, p = 0.032). After applying corrections for age,
sex and ICV, the left hippocampus volume showed signiﬁcant
correlation with the duration of JME (r = .382, p = 0.024), while
the right hippocampus volume showed signiﬁcant correlation with
the age at onset of illness (r = .388, p = 0.021).
3.2.4. Vertex based shape analysis
The shape analysis (FDR corrected, p < 0.05) revealed regional
areas of signiﬁcant shape difference in the bilateral thalami as
compared to the healthy controls (Fig. 2). Analysis showed
presence of regional shape abnormality in medial as well as
lateral aspects of the bilateral thalami. No areas of regional
expansion were noted when compared to the healthy controls.
Other structures did not show any morphological changes on
shape analysis. Shape analysis did not show any correlation with
the disease duration and age at onset of symptoms.h JME and controls with the region of interest analysis using the thalamic mask at
CV. Statistical design matrix isalso displayed. (A) shows the results in glass brain (B)
 in the superomedial aspect of bilateral thalami. ICV: intracranial volume; FDR: false
Table 2
Summary of subcortical volumes in patients with JME and controls.
Subcortical areas of brain JME Controls
Mean SD Mean SD p
Left amygdala (mm3) 1118.6 223.3 1182.2 238.1 NS
Right amygdala (mm3) 1156.9 325.4 1214.8 226.6 NS
Left caudate (mm3) 3238.7 409.5 3540.0 428.0 NS
Right caudate (mm3) 3389.0 417.5 3664.7 566.7 NS
Left putamen (mm3) 4476.0 555.0 4807.3 422.7 NS
Right putamen (mm3) 4656.9 540.3 4983.3 531.7 NS
Left thalamus (mm3) 6826.7 644.7 7826.2 639.9 <0.001
Right thalamus (mm3) 6560.9 622.4 7550.4 669.4 <0.001
Left hippocampus (mm3) 3474.2 584.3 3693.8 631.5 NS
Right hippocampus (mm3) 3601.5 555.5 4032.8 443.0 NS
Total GM (cm3) 590.6 101.8 693.1 123.8 NS
Total WM (cm3) 323.6 57.8 399.7 84.5 NS
TBV (cm3) 914.2 156.5 1092.7 206.2 NS
ICV (cm3) 1329.8 123.2 1432.8 157.9 NS
TBV: total brain volume; ICV: intracranial volume; GM: gray matter; WM: white
matter; NS: not signiﬁcant.
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The current study evaluated patients with JME using structural
MRI techniques, namely VBM, volumetry and shape analysis, for
identifying abnormalities of deep gray matter structures and
hippocampus. Using multiple techniques, we could demonstrate
thalamic morphological changes in JME. Shape analysis results
revealed regional shape differences in the thalamus of these
patients. Further, signiﬁcant correlation was noted between the
hippocampal volumes and disease duration suggesting hippocam-
pal structural alterations with prolonged illness in patients with
JME.
Previous results of VBM in JME have been inconsistent. Some
authors have reported increased GM concentration in the basi-
frontal region9 while others have observed decreased GM
concentration in the prefrontal region.12,20 Tae et al. reported
decreased cortical thickness in the frontal lobe.14 Previous VBM
studies have also reported increased GM concentration in the
mesial frontal region.7,10 Roebling et al. attributed these differ-
ences in the results of previous imaging studies to the differences
in study population, small sample size, methodological differences
and underlying genetic heterogeneity.32 Another major reason for
differences in earlier report was the use of different statistical
thresholds selected for reporting of results. In the study of Liu et al.,
the corrected VBM analysis showed no differences between patient
and control groups, the spatial extent cluster corrected VBMFig. 2. Comparison of the patients with JME and controls using vertex wise shape analy
indicating the Z score map; an increase from red to blue is going from a lower to higher s
and adjusted for age, sex and TBV. Anteromedial as well as lateral aspects of bilateral thala
discovery rate. (For interpretation of the references to color in the artwork, the readeranalysis suggested a trend of gray matter volume reduction in
frontal and central regions.33 Similarly, in the study by Roebling
et al., no differences were found and they used fully corrected VBM
analysis.32
The current study applied standard technique with similar
stringent statistical signiﬁcance levels as used in earlier stud-
ies.32,33 We also applied corrections for age, sex and ICV, as these
factors might also signiﬁcantly inﬂuence the results. However, on
using mask to observe for local changes in VBM analysis, focal
thalamic abnormality was observed. This was supported by shape
analysis which revealed multiple areas of focal shape abnormali-
ties in the thalamus. Our results indicate presence of regional
thalamic abnormalities in JME which could not be detected on
using whole brain analysis method. However with regards to the
thalamic structural changes also, variables ﬁndings have been
reported with some studies refuting presence of any alterations of
thalamus,9,22,34 while others reporting focal thalamic altera-
tions.10,20 MRS studies have shown neuronal loss in the form of
decreased NAA/Cr in the thalamus.16,31 Functional imaging study
using SPECT has also revealed perfusion disturbance in the
thalamus.13
In our study, we observed structural changes in the thalamus
using multiple methods of evaluation and large areas of focal shape
differences were seen in the anteromedial as well as lateral aspect
of the thalamus. Neuropsychological assessment of JME subjects
has shown presence of executive dysfunction which also
correlated with the thalamic and frontal atrophy in JME patients.11
These ﬁndings suggest that the thalamus might be a structural
correlate of the clinical dysfunction observed in these patients.
Though speculative, absence of structural changes in the thalamus
in whole brain VBM might be due to low prevalence of absence
seizures in our study cohort.
Previous VBM results10 and SPECT study13 found focal atrophy
and hypoperfusion of the ventrolateral thalami respectively, while
Mory et al.18 reported focal differences in the anterior and inferior
aspects of the thalamus. Focal abnormalities in the thalamus are
supported by involvement of speciﬁc thalamic nuclei noted during
spike wave discharges. Anterior, centromedian and parafascicular
nuclei activity has been recorded during the EEG-fMRI recordings
in idiopathic generalized epilepsy.35 Executive dysfunction ob-
served in the patients with JME also supports the involvement of
the anterior thalamic nucleus which in turn projects to the frontal
lobe. In future, improved MR resolution may allow us to identify
abnormalities of individual thalamic nuclei with greater conﬁ-
dence however results of the present study may be secondary to
abnormalities of the anterior and centromedian nuclei.sis of thalamus. The results are viewed from all the directions, with the color bar
tatistical signiﬁcance. Results are statistically signiﬁcant at p < 0.05 (FDR corrected)
mi showing signiﬁcant regional volume changes. TBV: total brain volume; FDR: false
 is referred to the web version of the article.)
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in the genesis of seizures but have been found to affect the cortical
excitability as well as modulating the seizure activity.36,37 In an
animal model with mutation affecting the BRD2 gene, it was
shown that animal with mutated gene had increased susceptibility
to GTCS and pathological analysis showed loss of GABAnergic
neurons in the neocortex, striatum, substantia nigra and ventral
medial thalamic nucleus.21 The BRD2 gene has been linked with
the presence of JME in humans.21 The putaminal abnormalities
have been found using 18F-Fallypride ([18F]FP) positron emission
tomography (PET), which demonstrated reduced dopamine
binding on the D2/D3 receptor of the posterior putamen in
patients with JME.38 Keller et al. have shown increased fractional
anisotropy and decreased volume of putamen in patients with
JME.19
One previous MRI study had evaluated basal ganglia for the
presence of structural changes using the technique of volumetry
and authors found decreased volume of putamen and caudate
nucleus in JME patients.22 In another investigation where subjects
of IGE with only GTCS were studied, volumetry revealed
signiﬁcantly decreased volumes of putamen and caudate nucle-
us.20 In our study structural abnormality in striatal regions in the
subjects were not detected. This variable result might be due to
differences in the study population, underlying genetic factors and
methodological differences. In our study, the majority of patients
was on treatment for variable duration as well as had all the
seizure types known to occur in JME. These factors might also
contribute toward variable results. JME is a genetically heteroge-
neous disease and has been associated with multiple gene
mutations. Further, these mutations have not been universally
present in all the ethnic populations.21 This genetic heterogeneity
and study of different population in previous imaging literature
may also account for variable results. Another possibility is that
basal ganglia may be functionally or biochemically abnormal as
revealed by MRS or PET studied but may not necessarily show
morphological alterations.
Bernasconi et al. speculated that the abnormalities observed in
patients of JME are related to disease duration and they increase
with passage of time.19 However, Pulsipher et al. found signiﬁcant
volumetric abnormalities in patients of JME who were analyzed
relatively early in the course of the disease.11 They reported
signiﬁcant neuropsychological abnormalities in these patients that
correlated with the volume loss observed on MRI study. They
hypothesized that structural abnormalities are present even before
the onset of ﬁrst seizure and they are possibly developmental in
origin.11 In the current study, lack of correlation between seizure
duration and volumetry of thalamus supports the observations of
Pulsipher et al.11
The other important ﬁnding in our study was signiﬁcant
correlation between hippocampus volumes and disease timeline
variables like disease duration and age at onset of disease.
However, no signiﬁcant hippocampal changes were noted in JME
subjects in both volumetric and shape analysis. Previous morpho-
logical studies have not been able to show structural abnormalities
of the hippocampus; however temporal lobe volume loss was
reported by Tae et al.12,14 In one of the SPECT study decreased rCBF
was noted in the left hippocampus.13 One recent MRS study has
also reported abnormal metabolite ratios in the both hippocam-
pi.23 Serotonin 1A receptor binding potential measured with PET
has revealed reduced binding potential in the hippocampus of
patients of JME.39 Although hippocampus is not directly involved
in the pathophysiology of JME, hippocampal abnormalities have
been documented in previous studies. Correlation has been
observed between the disease duration and age at onset of disease
in our study indicates presence of progressive hippocampal
damage. For deﬁnite conclusion we need to do serial evaluationto look for progressive changes. Correlation with seizure frequency
and number of seizures may also be useful. These changes might be
related to seizure spread leading to secondary hippocampal
damage reﬂected in structural and functional impairment revealed
by MRS and SPECT.
This study does not allow us to conclude cause-effect relations
for the JME and only makes an attempt to identify structural
changes in the subcortical structures. Important limitations of our
study are modest sample size and lack of longitudinal evaluation to
conﬁrm these ﬁndings. Longitudinal study may give answers to
many important questions like whether the structural changes are
progressive in nature or remain unchanged. It may also allow
studying the effects of medication and seizure control on brain
morphology. Another limitation was the possible effect of seizure
subtypes on structural abnormalities which may be one of the
important reasons for variations in the results of previous
neuroimaging studies. Selecting more homogenous seizure types
in future studies may provide better understanding about the
morphological changes in JME. However, this could not be carried
out in our study as there were only three patients with absence
seizures while majority had GTCS and myoclonic jerks. Another
factor that was not taken into account was the use of AEDs which
may also inﬂuence the brain morphology.40 Therefore these results
needs to be interpreted with caution and larger studies are
required to verify these ﬁndings.
In conclusion, the present study demonstrated structural
alterations in speciﬁc thalamic regions in patients with JME;
however it did not ﬁnd any signiﬁcant volume loss or shape
abnormality of striatum, amygdala and hippocampus. Shape
analysis is a useful adjunct to other structural analysis methods
as it may reveal complementary information.
Acknowledgment
This study was supported by partial funding from the
Department of Science and Technology, Govt. of India, New Delhi
(SR/SO/HS/108/2007). We appreciate the sincere efforts of Dr. P.R.
Naidu, MD; Medical advisor, Biocon Ltd. for copy/editing the
manuscript.
References
1. Panayiotopoulos CP, Obeid T, Tahan AR. Juvenile myoclonic epilepsy: a 5-year
prospective study. Epilepsia 1994;35(2):285–96.
2. Kobayashi E, Zifkin BG, Andermann F, Andermann E. Juvenile myoclonic epi-
lepsy. In: Engel J, Pedley TA, editors. Epilepsy: a comprehensive textbook. 2nd ed.
Philidelphia: Lippincott Williams & Wilkins; 2008. p. 2455–60.
3. Montalenti E, Imperiale D, Rovera A, Bergamasco B, Benna P. Clinical features,
EEG ﬁndings and diagnostic pitfalls in juvenile myoclonic epilepsy: a series of
63 patients. Journal of the Neurological Sciences 2001;184(1):65–70.
4. Delgado-Escueta AV, Enrile-Bacsal F. Juvenile myoclonic epilepsy of Janz.
Neurology 1984;34(3):285–94.
5. Pedersen SB, Petersen KA. Juvenile myoclonic epilepsy: clinical and EEG fea-
tures. Acta Neurologica Scandinavica 1998;97(3):160–3.
6. Holmes MD, Quiring J, Tucker DM. Evidence that juvenile myoclonic epilepsy is
a disorder of frontotemporal-cortico thalamic networks. Neuroimage
2010;49(1):80–93.
7. Woermann FG, Free SL, Koepp MJ, Ashburne J, Duncan JS. Voxel-by-voxel
comparison of automatically segmented cerebral gray matter-A rater-indepen-
dent comparison of structural MRI in patients with epilepsy. Neuroimage
1999;10(4):373–84.
8. Woermann FG, Free SL, Koepp MJ, Sisodiya SM, Duncan JS. Abnormal cerebral
structure in juvenile myoclonic epilepsy demonstrated with voxel-based anal-
ysis of MRI. Brain 1999;122:2101–8.
9. Betting LE, Mory SB, Li LM, Lopes-Cendes I, Guerreiro MM, Guerreiro CA, et al.
Voxel-based morphometry in patients with idiopathic generalized epilepsies.
Neuroimage 2006;32(2):498–502.
10. Kim JH, Lee JK, Koh SB, Lee SA, Lee JM, Kim SI, et al. Regional grey matter
abnormalities in juvenile myoclonic epilepsy: a voxel-based morphometry
study. Neuroimage 2007;37(4):1132–7.
11. Pulsipher DT, Seidenberg M, Guidotti L, Tuchscherer VN, Morton J, Sheth RD,
et al. Thalamofrontal circuitry and executive dysfunction in recent-onset
juvenile myoclonic epilepsy. Epilepsia 2009;50(5):1210–9.
J. Saini et al. / Seizure 22 (2013) 230–235 23512. Tae WS, Hong SB, Joo EY, Han SJ, Cho JW, Seo DW, et al. Structural brain
abnormalities in juvenile myoclonic epilepsy patients: volumetry and voxel-
based morphometry. Korean Journal of Radiology 2006;7(3):162–72.
13. Tae WS, Joo EY, Han SJ, Lee KH, Hong SB. CBF changes in drug naive juvenile
myoclonic epilepsy patients. Journal of Neurology 2007;254(8):1073–80.
14. Tae WS, Kim SH, Joo EY, Han SJ, Kim IY, Kim SI, et al. Cortical thickness
abnormality in juvenile myoclonic epilepsy. Journal of Neurology
2008;255(4):561–6.
15. Doelken MT, Mennecke A, Stadlbauer A, Kecskeme´ti L, Kasper BS, Struffert T,
et al. Multi-voxel magnetic resonance spectroscopy at 3 T in patients with
idiopathic generalised epilepsy. Seizure 2010;19(8):485–92.
16. Mory SB, Li LM, Guerreiro CA, Cendes F. Thalamic dysfunction in juvenile
myoclonic epilepsy: a proton MRS study. Epilepsia 2003;44(11):1402–5.
17. Haki C, Gu¨mu¨s¸ tas¸ OG, Bora I, Gu¨mu¨s¸ tas¸ AU, Parlak M. Proton magnetic reso-
nance spectroscopy study of bilateral thalamus in juvenile myoclonic epilepsy.
Seizure 2007;16(4):287–95.
18. Mory SM, Betting LE, Fernandes PT, Lopes-Cendes I, Guerreiro MM, Guerreiro
CA. Structural abnormalities of the thalamus in juvenile myoclonic epilepsy.
Epilepsy & Behavior 2011;21(4):407–11.
19. Bernasconi A, Bernasconi N, Natsume J, Antel SB, Andermann F, Arnold DL.
Magnetic resonance spectroscopy and imaging of the thalamus in idiopathic
generalized epilepsy. Brain 2003;126:2447–54.
20. Ciumas C, Savic I. Structural changes in patients with primary generalized tonic
and clonic seizures. Neurology 2006;67(4):683–6.
21. Velı´sˇek L, Shang E, Velı´sˇkova´ J, Chachua T, Macchiarulo S, Maglakelidze G, et al.
GABAergic neuron deﬁcit as an idiopathic generalized epilepsy mechanism: the
role of BRD2 haplo-insufﬁciency in juvenile myoclonic epilepsy. PLoS ONE
2011;6(8):e23656.
22. Seeck M, Dreifuss S, Lantz G, Jallon P, Foletti G, Despland PA, et al. Subcortical
nuclei volumetry in idiopathic generalized epilepsy. Epilepsia 2005;46:1642–5.
23. Ristic´ AJ, Ostojic´ J, Kozic´ D, Vojvodic´ NM, Popovic´ LM, Jankovic´ S, et al.
Hippocampal metabolic dysfunction in juvenile myoclonic epilepsy: 3D multi-
voxel spectroscopy study. Journal of the Neurological Sciences 2011;305(1-
2):139–42.
24. Proposal for revised classiﬁcation of epilepsies and epileptic syndromes. Com-
mission on classiﬁcation and terminology of the International League against
epilepsy. Epilepsia 1989;30:389–99.
25. Nordli Jr DR. Idiopathic generalized epilepsies recognized by the International
League against Epilepsy. Epilepsia 2005;46(Suppl. 9):48–56.
26. Ashburner J, Friston K. Voxel-based morphometry – the methods. NeuroImage
2000;1:805–21.27. Ashburner J, Friston KJ. Uniﬁed segmentation. Neuroimage 2005;26(3):839–51.
28. Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS. A
voxel-based morphometric study of ageing in 465 normal adult human brains.
NeuroImage 2001;14:21–36.
29. Patenaude B, Smith SM, Kennedy DN, Jenkinson M. A Bayesian model of shape
and appearance for subcortical brain segmentation. Neuroimage 2011;56(3):
907–22.
30. Lancaster JL, Woldorff MG, Parsons LM, Liotti M, Freitas CS, Rainey L, et al.
Automated Talairach atlas labels for functional brain mapping. Human Brain
Mapping 2000;10(3):120–31.
31. Lin K, CarreteJr H, Lin J, Peruchi MM, de AraujoFilho GM, Guaranha MS.
Magnetic resonance spectroscopy reveals an epileptic network in juvenile
myoclonic epilepsy. Epilepsia 2009;50(5):1191–200.
32. Roebling R, Scheerer N, Uttner I, Gruber O, Kraf E, Lerche H. Evaluation of
cognition, structural, and functional MRI in juvenile myoclonic epilepsy. Epi-
lepsia 2009;50:2456–65.
33. Liu M, Concha L, Beaulieu C, Gross DW. Distinct white matter abnormalities in
different idiopathic generalized epilepsy syndromes. Epilepsia 2011;52(12):
2267–75.
34. Natsume J, Bernasconi N, Andermann F, Bernasconi A. MRI volumetry of the
thalamus in temporal, extratemporal, and idiopathic generalized epilepsy.
Neurology 2003;60:1296–300.
35. Tyvaert L, Chassagnon S, Sadikot A, LeVan P, Dubeau F, Gotman J. Thalamic
nuclei activity in idiopathic generalized epilepsy: an EEG-fMRI study. Neurology
2009;73:2018–22.
36. Slaght SJ, Paz T, Mahon S, Maurice N, Charpier S, Deniau JM. Functional
organization of the circuits connecting the cerebral cortex and the basal
ganglia: implications for the role of the basal ganglia in epilepsy. Epileptic
Disorders 2002;4(Suppl. 3):9–22.
37. Deransart C, Depaulis A. The control of seizures by the basal ganglia?. A review
of experimental data. Epileptic Disorders 2002;4(Suppl. 3):S61–S72.
38. Landvogt C, Buchholz HG, Bernedo V, Schreckenberger M, Werhahn KJ. Alter-
ation of dopamine D2/D3 receptor binding in patients with juvenile myoclonic
epilepsy. Epilepsia 2010;51:1699–706.
39. Meschaks A, Lindstrom P, Halldin C, Farde L, Savic I. Regional reductions in
serotonin 1A receptor binding in juvenile myoclonic epilepsy. Archives of
Neurology 2005;62(6):946–50.
40. Papazian O, Canizales E, Alfonso I, Archila R, Duchowny M, Aicardi J. Reversible
dementia and apparent brain atrophy during valproate therapy. Annals of
Neurology 1995;38:687–91.
